International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
NCT ID: NCT05590715
Last Updated: 2025-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1500 participants
OBSERVATIONAL
2022-10-13
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characterization of a Clinical Subpopulation With Autism Spectrum Disorder
NCT04273087
Phenotypic and Genetic Factors in Autism Spectrum Disorders
NCT00910559
Autism Spectrum Disorders (ASD) Characterization Study
NCT00801554
Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder
NCT04600882
A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD)
NCT03611075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Available well-documented health records within the first 2 years of life
* Participants must have a parent or reliable caregiver who agrees to provide information about the participant
* Participants willing and consenting or assenting to participate.
Exclusion Criteria
* If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study.
12 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stalicla SA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paulo Fontoura, MD, PhD
Role: STUDY_DIRECTOR
Stalicla SA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SARRC
Phoenix, Arizona, United States
California Neuroscience Research
Sherman Oaks, California, United States
BioPhase Research
Miami, Florida, United States
The Angel Medical Research
Miami Lakes, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders
Columbia, Missouri, United States
Golden Hearts Diagnostic
Alamogordo, New Mexico, United States
Red Oak Psychiatry Associates
Houston, Texas, United States
Alpine Research Organization
Clinton, Utah, United States
Children's Health Queensland Hospital and Health Service
South Brisbane, Queensland, Australia
Mater Misericordiae Limited
South Brisbane, Queensland, Australia
Flinders Medical Centre
Bedford Park, South Australia, Australia
Locuspsych
Melbourne, Victoria, Australia
Murdoch Children's Research Institute
Parkville, Victoria, Australia
Hospital General Universitario Dr Balmis
Alicante, , Spain
Hospital Clinic of Barcelona
Barcelona, , Spain
Hospital Infantil Universitario Nino Jesus (HIUNJS)
Madrid, , Spain
Hospital universitario Infanta Leonor
Madrid, , Spain
Hospital Universitario Puerta De Hierro Majadahonda
Majadahonda, , Spain
Policlina Gipuzkoa
San Sebastián, , Spain
Hospital Álvaro Cunqueiro
Vigo, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Melissa Baer
Role: primary
Nicole Takahashi
Role: primary
Amy Kenley
Role: primary
Emily Milburn
Role: primary
Caitlin Bennett
Role: primary
Rupali Saikia
Role: primary
Kylie Crompton
Role: primary
Maria Auxiliadora Javaloyes Sanchis, MD
Role: primary
Rosa Calvo Escalona, MD/PhD
Role: primary
Silvia Gutierrez Priego, MD
Role: primary
Francisco Javier Quintero Gutiérrez del Álamo, MD/PhD
Role: primary
Jose Manuel Olivares Diez, MD/PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STA-B-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.